1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)


SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

Cell lines tested with tretinoin:navitoclax (4:1 mol/mol)

825 cell lines have been tested with this compound, using data from 1 dataset(s).
A549 lung CTRPv23
DU-145 prostate CTRPv22
AsPC-1 pancreas CTRPv22
NCI-H1869 lung CTRPv22
CCF-STTG1 central nervous system CTRPv22
OAW-28 ovary CTRPv22
HeLa cervix CTRPv22
NCI-H520 lung CTRPv22
MKN74 stomach CTRPv22
IGROV-1 ovary CTRPv22
Download CSV

Tissues tested with tretinoin:navitoclax (4:1 mol/mol)

25 tissues have been tested with this compound, using data from 1 dataset(s).
haematopoietic and lymphoid tissueCTRPv2146
central nervous systemCTRPv247
large intestineCTRPv241
Download CSV
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)

Feature TypeStandardized
Nominal ANOVA
mRNA CECR6 CTRPv2 AAC 0.27 6e-15
mRNA PARVG CTRPv2 AAC 0.27 2e-12
mRNA IRF2BP2 CTRPv2 AAC 0.25 3e-12
mRNA ARHGAP33 CTRPv2 AAC 0.25 5e-12
mRNA SATB1 CTRPv2 AAC 0.25 7e-12
mRNA BAHCC1 CTRPv2 AAC 0.24 1e-11
mRNA KIAA1147 CTRPv2 AAC 0.24 3e-11
mRNA ATL1 CTRPv2 AAC 0.25 3e-11
mRNA STXBP5L CTRPv2 AAC 0.23 3e-11
mRNA FXYD6 CTRPv2 AAC 0.24 1e-10
Download CSV